FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and represents a pharmaceutical composition for prevention and treatment of the metabolic syndrome and diabetic nephropathy, which contains the following active substances: taurine, a dry extract of motherwort herb, a dry extract of hawthorn fruit and accessory substances, with components present in the composition in a specified ratio in wt %.
EFFECT: invention provides extension of the arsenal of means for prevention and treatment of the metabolic syndrome and diabetic nephropathy.
10 cl, 13 ex, 19 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY, CARDIO- AND CHONDROPROTECTIVE ACTIVITY, ACTION PREVENTING GASTROPATHIES CAUSED BY NSAID, AND METHOD FOR PREPARING IT | 2011 |
|
RU2502507C2 |
PREPARATION FLAVOSUCCINE FOR TREATING AND PREVENTING RENAL AND URINARY DISEASES | 2010 |
|
RU2456011C1 |
PREPARATION "VENOGEPANOL" FOR TREATMENT AND PROPHYLAXIS OF VESSEL AND TISSUE PATHOLOGICAL INJURE | 2003 |
|
RU2238737C1 |
HEPATOPROTECTIVE AGENT | 2002 |
|
RU2211034C1 |
PHARMACEUTICAL COMPOSITION BASED ON GREEN COFFEE BERRY EXTRACT, METHOD FOR MAKING AND APPLYING | 2008 |
|
RU2378003C1 |
AGENT FOR TREATMENT OF MEN WITH SEXUAL DYSFUNCTION | 2000 |
|
RU2163805C1 |
AGENT FOR TREATMENT OF MEN WITH SEXUAL DYSFUNCTION | 1999 |
|
RU2163806C1 |
PHARMACEUTICAL ANTIDIABETIC COMPOSITION BASED ON (+)-CIS-3-(1H-BENZIMIDAZOL-2-YL)-1,2,2-TRIMETHYLCYCLOPENTANE CARBOXYLIC ACID | 2016 |
|
RU2624872C1 |
COMPOSITION FOR METABOLIC SYNDROME CORRECTION | 2016 |
|
RU2616241C1 |
ELIXIR EXHIBITING SEDATIVE AND GENERAL TONIC EFFECT | 2000 |
|
RU2171114C1 |
Authors
Dates
2014-06-20—Published
2011-06-24—Filed